Matthew W. Foehr - Jun 10, 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
By: Charles S. Berkman For: Matthew W. Foehr
Stock symbol
LGND
Transactions as of
Jun 10, 2022
Transactions value $
$0
Form type
4
Date filed
6/14/2022, 05:55 PM
Previous filing
May 13, 2022
Next filing
Sep 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Award $0 +9.14K +5.27% $0.00 182K Jun 10, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.